» Authors » Raksha Rao

Raksha Rao

Explore the profile of Raksha Rao including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 30
Citations 439
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sen M, Rao R, Mulay K, Reddy V, Honavar S
Ophthalmology . 2024 May; 131(10):1215-1224. PMID: 38703794
Purpose: To study the long-term efficacy of intravitreal topotecan (IVT) for vitreous seeds in eyes with retinoblastoma and risk factors for their recurrence. Design: Retrospective, non-comparative, interventional study. Participants: Ninety-one...
2.
Turkoglu E, Rao R, Celik E
Photodiagnosis Photodyn Ther . 2022 Apr; 38:102840. PMID: 35367617
Purpose: To report the outcome of photodynamic therapy (PDT) for choroidal melanoma as adjuvant treatment with CyberKnife radiotherapy. Design: Retrospective interventional case series. Methods: Standard-fluence PDT using verteporfin. Outcome Measures:...
3.
Thakare A, Ghosh C, Alalamath T, Kumar N, Narang H, Whadgar S, et al.
Sci Rep . 2022 Mar; 12(1):3610. PMID: 35246568
Anopheles stephensi is the most menacing malaria vector to watch for in newly urbanising parts of the world. Its fitness is reported to be a direct consequence of the vector...
4.
Vasanthapuram V, Gupta R, Adulkar N, Nair A, Bradoo R, Hegde R, et al.
Orbit . 2022 Feb; 42(1):30-41. PMID: 35192435
Purpose: To study the risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis (ROCM) during the COVID-19 pandemic in India. Methods: Multi-centric retrospective case-control study conducted from October 2020 to...
5.
Rao R, Honavar S, Lahane S, Mulay K, Reddy V
Br J Ophthalmol . 2021 Nov; 107(5):621-626. PMID: 34844918
Background/aim: To evaluate the safety and efficacy of ruthenium-106 (Ru-106) plaque brachytherapy in managing invasive ocular surface squamous neoplasia (OSSN). Methods: This is a retrospective, non-comparative, interventional case series of...
6.
Bansal R, Aishwarya A, Rao R, Christy M, Sen M, Regani H, et al.
Indian J Ophthalmol . 2021 Sep; 69(10):2617-2624. PMID: 34571599
Purpose: The novel coronavirus SARS-CoV-2 (COVID-19) and the resultant nationwide lockdown and travel restrictions led to difficulty in providing timely and regular treatment to patients with childhood cancers such as...
7.
Nagesh C, Rao R, Hiremath S, Honavar S
Indian J Ophthalmol . 2021 Sep; 69(10):2585-2616. PMID: 34571598
In this article we focus on a systematic approach to assess common orbital lesions on magnetic resonance imaging (MRI). The identification of the probable compartment or structure of origin helps...
8.
Nagesh C, Rao R, Hiremath S, Honavar S
Indian J Ophthalmol . 2021 Sep; 69(10):2574-2584. PMID: 34571597
Magnetic resonance imaging (MRI) is an eloquent, noninvasive, cross-sectional imaging modality that offers superior tissue characterization of orbital pathologies. The ophthalmologist needs to be aware of the advantages of MRI...
9.
Sen M, Honavar S, Bansal R, Sengupta S, Rao R, Kim U, et al.
Indian J Ophthalmol . 2021 Jun; 69(7):1670-1692. PMID: 34156034
Purpose: COVID-19-associated rhino-orbital-cerebral mucormycosis (ROCM) has reached epidemic proportion during India's second wave of COVID-19 pandemic, with several risk factors being implicated in its pathogenesis. This study aimed to determine...
10.
Rao R, Shetty A, Nagesh C
Indian J Ophthalmol . 2021 May; 69(6):1627-1630. PMID: 34011758
Orbital infarction syndrome is an uncommon pathology with devastating consequences. It is frequently secondary to atherothrombotic phenomena in the internal carotid artery. We report a case of a 66-year-old male...